Clinical Research On Leg Deep Vein Thrombosis Treated By The Optimized Protocol Of Integrated TCM And WM

Objective:The research projects based on the modern pharmacological research and Syndrome Differentiation and Treatment, compared with the 2006 program to further explore the clinical treatment of deep venous thrombosis of the optimization. Integrative Medicine further confirmed deep venous thrombosis of the strengths and characteristics.Methods:Random number table with 60 patients divided into two groups, to optimize the program for the observation group (30 cases, after falling 1 case), the 2006 program for the control group (30 cases, after falling 1 case), Overall effect of the two groups, changes in limb circumference and blood rheology changes were observed. General physical examination,the three conventional (blood, urine, then normal), liver and kidney function, ECG changes and other safety indicators were also observed before and after treatment project, to assess whether the related adverse reactions.Results:After 15 days of treatment, the overall efficacy rate was:96.55% in observation group and control group 79.31%, and the observation group was better than the control group (p<0.05); Doppler ultrasonography showed efficacy rate was:96.55% in observation group and control group 82.75%, and the observation group was better than the control group (p<0.05); Two groups significantly improved blood rheology (P<0.05), pharmacoeconomic analysis study better in the observation group than in the control group. Before and after treatment in both groups had no significant abnormal security index, the treatment process does not appear obvious adverse reactions.Conclusion:1.Optimization of treatment of lower extremity deep venous thrombosis gave the overall effect and limb circumference significant improvement effect, the effect of Doppler ultrasonography showed significant improvement, and better than the 2006 program.2.Optimization of treatment can significantly improve the treatment of deep venous thrombosis of hemorheology, and are better than the 2006 program..3.The use of drugs combined with economic analysis to optimize treatment is superior to the 2006 program.4. Optimization of treatment were without obvious adverse effects, and clinical application was security.